1. Home
  2. AME vs TAK Comparison

AME vs TAK Comparison

Compare AME & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMETEK Inc.

AME

AMETEK Inc.

HOLD

Current Price

$196.97

Market Cap

44.5B

Sector

Industrials

ML Signal

HOLD

Logo Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

TAK

Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

HOLD

Current Price

$14.31

Market Cap

43.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AME
TAK
Founded
1930
1781
Country
United States
Japan
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
44.5B
43.3B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AME
TAK
Price
$196.97
$14.31
Analyst Decision
Buy
Analyst Count
10
0
Target Price
$213.00
N/A
AVG Volume (30 Days)
1.4M
3.2M
Earning Date
10-30-2025
10-30-2025
Dividend Yield
0.63%
1.91%
EPS Growth
10.46
N/A
EPS
6.34
0.14
Revenue
$7,164,270,000.00
$29,846,840,032.00
Revenue This Year
$6.18
$0.01
Revenue Next Year
$7.53
$0.49
P/E Ratio
$30.85
$103.78
Revenue Growth
3.67
N/A
52 Week Low
$145.02
$12.80
52 Week High
$204.15
$15.69

Technical Indicators

Market Signals
Indicator
AME
TAK
Relative Strength Index (RSI) 56.75 54.45
Support Level $188.47 $14.38
Resistance Level $198.53 $14.54
Average True Range (ATR) 3.44 0.15
MACD 0.01 0.05
Stochastic Oscillator 69.36 62.16

Price Performance

Historical Comparison
AME
TAK

About AME AMETEK Inc.

Founded in 1930 and transformed over the decades through the acquisition of dozens of esteemed brands, Ametek owns a collection of over 40 autonomous industrial businesses operating within the research, aerospace, energy, medical, and manufacturing industries. Ametek segments its business into two operating groups: the electronic instruments group and the electromechanical group. The EIG sells a broad portfolio of analytical, test, and measurement instruments, while the EMG sells highly engineered components, interconnects, and specialty metals. The company emphasizes product differentiation and market leadership in the niche markets where it operates.

About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.

Share on Social Networks: